DOCSLIB.ORG

Media Preparation SOP 5

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Media Preparation SOP 5 CARIBBEAN REGIONAL MICROBIOLOGY STANDARD OPERATING PROCEDURES Media Preparation and Quality Control – SOP No: CRM-SOP 18 CAREC PAHO WHO EUROPEAN UNION STRENGTHENING OF MEDICAL LABORATORY SERVICES IN THE CARIBBEAN A CARIFORUM Project Funded by the European Union and Implemented by CAREC Media Preparation and Quality Control Title: Media Preparation and Quality Control SOP Number: CRM-SOP: 18 Version: 1 Page Number: 1 of 102 Prepared By: Caribbean Regional Standard Effective Date: 1st September 2007 Methods Drafting Group Review Date: 1st September 2008 TABLE OF CONTENTS Amendment procedure 4 Introduction 5 Media production process flow chart 5 1. Media Preparation and Quality Control 6 1.1 Introduction 6 1.2 Types of Media 6 1.3 Media Production 10 2.0 Media Quality Control Methods 11 2.1 Introduction 11 2.2 Principles of QC of Media 11 2.3 Shelf-life 11 2.4 Standardization of Laboratory Media 12 2.5 Control Medium 12 2.6 Test Programme 12 2.7 Physical Characteristics 12 2.8 Quality documentation 12 2.9 Methods 12 2.10 Examination of Physical Characteristics 13 2.11 Test for Microbiological Performance 14 2.12 QC Tests for Solid Media 14 2.13 QC Tests for Liquid Media 15 2.14 Interpretation of Microbiological Tests on Liquid Media 15 2.15 Sterility Tests 15 2.16 Quality Control Limits for Haemophilus Test Medium Agar 15 2.17 Storage of Culture Media 16 3.0 Quality Control of Culture Media Prepared In-house 16 3.1 Procedure 16 3.2 Quality Control Protocols 16 4.0 Quality Control of Commercially Prepared Media 18 4.1 Exempt Media Category 18 4.2 Nonexempt Media Category. 18 4.3 General QC Requirements for both Exempt and Nonexempt Media 19 4.4 Q.C. Requirements for Nonexempt Media Only 19 4.5 Reporting Deficiencies Identified by the User 19 5.0 Quality Control of Media not included in Section 6 20 6.0 Methods 24 6.1 Preparation of Alkaline Peptone Water 24 6.2 Preparation of Blood Agar 26 6.3 Preparation of Bile Esculin Agar 28 6.4 Preparation of Baird Parker Agar 30 6.5 Preparation of Bile Esculin Azide Agar 31 6.6 Preparation of Chocolate Agar 34 6.7 Preparation of CLED Agar 36 STRENGTHENING OF MEDICAL LABORATORY SERVICES IN THE CARIBBEAN 1 A CARIFORUM Project Funded by the European Union and Implemented by CAREC Media Preparation and Quality Control Title: Media Preparation and Quality Control SOP Number: CRM-SOP: 18 Version: 1 Page Number: 2 of 102 Prepared By: Caribbean Regional Standard Effective Date: 1st September 2007 Methods Drafting Group Review Date: 1st September 2008 6.8 Preparation of Cooked Meat Medium 38 6.9 Preparation of Brain Heart Infusion Broth 40 6.10 Preparation of Brain Heart Infusion Agar 42 6.11 Preparation of GN Broth 44 6.12 Preparation of Haemophilus Test Medium (HTM) Agar 46 6.13 Preparation of MacConkey Agar 48 6.14 Preparation of MacConkey Agar with Sorbitol 50 6.15 Preparation of Mueller Hinton (MH) Agar 52 6.16 Preparation of Nutrient Agar 54 6.17 Preparation of New York City (NYC) Medium 56 6.18 Preparation of Peptone Water 58 6.19 Preparation of Phenylethyl Alcohol (PEA) Agar 60 6.20 Preparation of Phenylalanine Agar 62 6.21 Preparation of Mannitol Salt Agar (MSA) 64 6.22 Preparation of Sabouraud Dextrose Agar 66 6.23 Preparation of Thayer Martin (TM) Agar 68 6.24 Preparation of Xylose Lysine Deoxycholate (XLD) Agar 70 6.25 Preparation of Thiosulphate Citrate Bile Salt Sucrose (TCBS) Agar 72 6.26 Preparation of Trichosel Broth 74 6.27 Preparation of Tetrathionate Broth 76 6.28 Preparation of Candida Bromcresol Green (BCG) Agar 78 6.29 Preparation of CHROMagar 80 6.30 Preparation of Lim Broth 82 6.31 Preparation of Kligler Iron Agar (KIA) 84 6.32 Preparation of Urea 86 6.33 Preparation of Simmons Citrate 88 6.34 Preparation of MILS Medium 90 6.35 Preparation of Triple Sugar Iron (TSI) Agar 93 7.0 References 96 Appendix 1: Preparation of Media (Flowchart) 97 Appendix 2: Preparation of Suspensions for Quality Control of Nonexempt Media 98 Appendix 3: Media Quality Control Record Sheet 99 Appendix 4: Media Quality Control Sheet 100 Appendix 5: Exempt and Non-exempt Categories for Media 102 STRENGTHENING OF MEDICAL LABORATORY SERVICES IN THE CARIBBEAN 2 A CARIFORUM Project Funded by the European Union and Implemented by CAREC Media Preparation and Quality Control Title: Media Preparation and Quality Control SOP Number: CRM-SOP: 18 Version: 1 Page Number: 3 of 102 Prepared By: Caribbean Regional Standard Effective Date: 1st September 2007 Methods Drafting Group Review Date: 1st September 2008 Acknowledgements The ‘Strengthening of Medical Laboratory Services in the Caribbean’ (SMLS) Project, would like to thank the following people for their participation in researching and writing the microbiology standard methods, and also the individual countries for supporting this initiative. Many thanks also for the facilitators of the standard methods meetings, the method editors and administrative support. Participants Country Name Organisation Aruba Ms. Astrid Dirksz Landslaboratorium Anguilla Ms. Everette Duncan Princess Alexandra Hospital, Stoney Ground Bahamas Mr. Allison Scavella Princess Margaret Hospital Barbados Ms. Gail Trotman Public Health Laboratory Ms. Juliana Applewaite Queen Elizabeth Hospital Mr. Edmund Blades Public Health Laboratory Belize Ms. Solitaire Parra Maza Central Medical Laboratory British Virgin Islands Ms. Allene Brewley Peebles Hospital Ms. June Greene Medicure Ltd. Ms. Wayveney Armstrong MEDICAL Diagnostic Laboratory Cayman Islands Mr. Dale Andrew Chin Caymans Islands Health Services Authority Curacao Mr. Osric Wanga Analytical Diagnostic Centre Ms. Helga Leito Analytical Diagnostic Centre Grenada Ms. Sonia Ann Edwards St Georges Hospital Guyana Ms. Alexis Wilson Pearson Georgetown Public Hospital Ms. Ede Tyrell Langevine University of Guyana Jamaica Ms. Rayaad Khan Central Medical Laboratories Ltd Ms. Valerie Levy UWI Microbiology Department Ms. Heather Wint Caledonia Medical Laboratory (Biomedical) Ms. Adriene Kellier Cornwall Regional Hospital Mr. Norman S. Burke National Public Health Laboratory St Lucia Mr. Martin S. Mc Kenzie Ezra Long Laboratory St Vincent and Mr. Elliot Samuel Milton Cato Memorial Hospital the Grenadines Caribbean Epidemiology Ms. Radha Gosein CAREC Centre (CAREC) Ms. Michele Nurse-Lucas CAREC Ms. Denise Clarke CAREC Dr. Ashok Rattan CAREC Trinidad Ms. Zobida Khan Mohammed Trinidad Public Health Laboratory (TPHL) Mr. Anthony Bayley Trinidad Public Health Laboratory (TPHL) Mr. Jawaheerlal Mewahlal College Of Science, Technology And Applied Arts of Trinidad and Tobago (COSTAATT) Ms. Monica Pollard Port of Spain General Hospital Dr. William Swanston Eric Williams Sciences Medical Complex Turks and Caicos Islands Ms. Lessonjule Lyons Doney Grand Turk General Hospital Laboratory Ms. Peggy Hermitt Myrtle Rigby Hospital STRENGTHENING OF MEDICAL LABORATORY SERVICES IN THE CARIBBEAN 3 A CARIFORUM Project Funded by the European Union and Implemented by CAREC Media Preparation and Quality Control Title: Media Preparation and Quality Control SOP Number: CRM-SOP: 18 Version: 1 Page Number: 4 of 102 Prepared By: Caribbean Regional Standard Effective Date: 1st September 2007 Methods Drafting Group Review Date: 1st September 2008 Facilitators/Editors Country Name Organisation Canada Dr Harold Richardson Quality Management Program – Laboratory Section Trinidad Ms. Julie Sims Strengthening of Medical Laboratory Services in the Caribbean (SMLS) United Kingdom Ms. Jacki Watts Bristol Health Protection Agency United Kingdom Ms. Valerie Bevan Health Protection Agency (HPA UK)* Administrative Support Function Name Organisation Administrative Support Ms. Stacey-Mae Stephens SMLS Project Administrative Support Ms. Reesa Moonsie SMLS Project Rapporteur Ms. Margaret Hunte Independent Graphic Design and Support Function Name Country Graphic Design Ms. Cathleen Jones Trinidad & Tobago Graphic Support Mr. Adrian Nicholls United Kingdom Graphic Support Ms. Karen Lara-Augustine Trinidad & Tobago *The Health Protection Agency, England, is acknowledged for the knowledge and expertise of their staff and working groups in the UK who develop National Standard Methods, on which the Caribbean Regional Microbiology Standard Operating Procedures are based. STRENGTHENING OF MEDICAL LABORATORY SERVICES IN THE CARIBBEAN 4 A CARIFORUM Project Funded by the European Union and Implemented by CAREC Media Preparation and Quality Control Title: Media Preparation and Quality Control SOP Number: CRM-SOP: 18 Version: 1 Page Number: 5 of 102 Prepared By: Caribbean Regional Standard Effective Date: 1st September 2007 Methods Drafting Group Review Date: 1st September 2008 INTRODUCTION The Caribbean Regional Standard Methods include a selection will be based on a review of EQA results, most variety of standard, validated methods, produced as common and/or critical tests. Part of the method a single standard operating procedure (SOP) for use in a standardization process will be an ongoing review and variety of levels of microbiology laboratory service. amendment procedure. The CSMDG consists of It is intended that these methods provide detailed microbiology laboratory representatives from most of instructions for microbiology services for microbiological the CARIFORUM countries, all of whom were nominated investigations, in order to provide accurate, reliable and to the task by the CRMC. reproducible results which will have clinical utility. These methods may be adopted by laboratories within the This initiative should enable the region to implement a region, or adapted, provided that such adaptations
Load more

Recommended publications
  • Microbiology Laboratory Exercises Third Edition 2020
    MICROBIOLOGY Laboratory Exercises Third Edition Keddis & Rauschenbach 2020 Photo Credits (in order of contribution): Diane Davis, Ines Rauschenbach & Ramaydalis Keddis Acknowledgements: Many thanks to those in the Department of Biochemistry and Microbiology, Rutgers University, who have through the years inspired our enthusiasm for the science and teaching of microbiology, with special thanks to Diane Davis, Douglas Eveleigh and Max Häggblom. Safety: The experiments included in this manual have been deemed safe by the authors when all necessary safety precautions are met. The authors recommend maintaining biosafety level 2 in the laboratory setting and using risk level 1 organisms for all exercises. License: This work is licensed under a Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International License Microbiology Laboratory Exercises Third Edition 2020 Ramaydalis Keddis, Ph.D. Ines Rauschenbach, Ph.D. Department of Biochemistry and Microbiology Rutgers, The State University of New Jersey CONTENTS PAGE Introduction Schedule ii Best Laboratory Practices Iii Working in a Microbiology Laboratory iv Exercises Preparation of a Culture Medium 1 Culturing and Handling Microorganisms 3 Isolation of a Pure Culture 5 Counting Bacterial Populations 8 Controlling Microorganisms 10 Disinfectants 10 Antimicrobial Agents: Susceptibility Testing 12 Hand Washing 14 The Lethal Effects of Ultraviolet Light 15 Selection of Fungi from Air 17 Microscopy 21 Morphology and Staining of Bacteria 26 Microbial Metabolism 30 Enzyme Assay 32 Metabolic
    [Show full text]
  • Rapid Identification Ofbacteroides Fragilis with Bile and Antibiotic Disks D
    JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Vol. 5, No. 4 Copyright C 1977 American Society for Microbiology Printed in U.S.A. Rapid Identification ofBacteroides fragilis with Bile and Antibiotic Disks D. L. DRAPER1 AND A. L. BARRY* Section ofInfectious and Immunologic Diseases, School of Medicine, University of California, Davis, California 95616, and Clinical Microbiology Laboratories, Medical Center, Sacramento, California 95817* Received for publication 21 December 1976 A simple screening test is described for separating Bacteroides fragilis from other anaerobic gram-negative bacilli. The test utilizes filter paper disks im- pregnated with 25 mg of oxgall (Difco), tested in conjunction with antibiotic identification disks. The bile disks and antibiotic disks are placed on a supple- mented brucella blood agar plate which has been inoculated by swabbing with a standardized cell suspension. After 24 h at 350C in a GasPak jar, resistance to kanamycin and bile is taken as a presumptive identification of B. fragilis. Susceptibility to one or both disks indicates the need for further identification and additional biochemical tests are required. Those strains that produce insuf- ficient growth within 24 h are not likely to be B. fragilis. The reliability of the bile disk method was tested by comparing results with 100 clinical isolates versus results with bile in thioglycolate broth, peptone-yeast extract-glucose broth, and tryptic soy agar. All four bile test methods gave equilvalent results, but the broth media required much longer periods of incubation. Bacteroides fragilis is the anaerobic gram- would quickly identify most B. fragilis strains negative bacillus most frequently recovered could significantly reduce the number of iso- from human infections.
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • Obligate Anaerobe in Thioglycollate Medium
    Obligate Anaerobe In Thioglycollate Medium Restiform and pernicious Monty addled her libertarians chastens rurally or alluding drawlingly, is Lorne ungainful? Ernst often laicises intrusively when haustellate Talbert underpeep parchedly and skiagraph her therapies. Adair uncanonizing shily as Mozartean Gifford tellurizing her unsociableness disentwining septically. Anaerobic bacteria can be identified by separate them in test tubes of thioglycollate broth. Aerobic and Anaerobic Growth Lab Exercise 6 Sp16 Canvas. Enriched Thioglycollate Broth is recommended for the isolation cultivation and identification of society wide following of obligate anaerobic bacteria Composition. How to the center of oxygen allowing the pus should not as they may live session is medium in thioglycollate are entire plate in air and aerobic respiration. We extend such an organism an aerotolerant anaerobe and set just off against an additional category of oxygen relationship Those left black the facultative. A movie free from thioglycollate for the growth of aerobic and anaerobic. Opened under a medium onto a medium on medium low, obligate anaerobe in thioglycollate medium, obligate and environmental parameters. Anaerobic Thioglycollate Medium Base Himedia. Find each pipette, obligate anaerobe growth. Incubation obligate anaerobes will grow abnormal in that portion of turkey broth for the. Obligate Anaerobes are actually poisoned by various forms of oxygen. Enriched Thioglycollate Broth M73 VWR. BBL Thioglycollate Medium Enriched with CiteSeerX. The model organism Escherichia coli is a facultative anaerobic bacterium ie it is solar to operate in both aerobic and anaerobic environments. Thioglycollate medium Difco containing 1 dextrose and B. Oxygen Requirements for Microbial Growth Microbiology. Fluid Thioglycollate Medium Flashcards Quizlet. The Thioglycolate medium other the word hand stands out fast its ability to.
    [Show full text]
  • Isolation of Rhizobacteria in Southwestern Québec, Canada: An
    Isolation of rhizobacteria in Southwestern Québec, Canada: An investigation of their impact on the growth and salinity stress alleviation in Arabidopsis thaliana and crop plants Di Fan Department of Plant Science Faculty of Agricultural and Environmental Sciences Macdonald Campus of McGill University 21111 Lakeshore Road, Sainte-Anne-de-Bellevue, Québec H9X 3V9 December 2017 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of DOCTOR OF PHILOSOPHY © Di Fan, Canada, 2017 Table of contents Abstract ................................................................................................. x Résumé ................................................................................................ xiii Acknowledegments ............................................................................. xv Preface ................................................................................................ xviii Contribution of authors ................................................................................ xviii Chapter 1................................................................................................. 1 Introduction ............................................................................................ 1 Chapter 2................................................................................................. 5 Literature Review ................................................................................... 5 2.1 What are root exudates? .........................................................................
    [Show full text]
  • 2017 Proceedings Book
    2017 30TH PROCEEDINGS OF NAVDF April 26-29, 2017 ORLANDO, FLORIDA 2 (orfenicol, terbinane, mometasone furoate) Otic Solution Antibacterial, antifungal, and anti-inammatory For Otic Use in Dogs Only The following information is a summary of the complete product information and is not comprehensive. Please refer to the approved product label for complete product information prior to use. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. PRODUCT DESCRIPTION: CLARO® contains 16.6 mg/mL orfenicol, 14.8 mg/mL terbinane (equivalent to 16.6 mg/mL terbinane hydrochloride) and 2.2 mg/mL mometasone furoate. Inactive ingredients include puried water, propylene carbonate, propylene glycol, ethyl alcohol, and polyethylene glycol. INDICATIONS: CLARO® is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). DOSAGE AND ADMINISTRATION: CLARO® should be administered by veterinary personnel. Administration is one dose (1 dropperette) per aected ear. The duration of eect should last 30 days. Clean and dry the external ear canal before administering the product. Verify the tympanic membrane is intact prior to administration. Cleaning the ear after dosing may aect product eectiveness. Refer to product label for complete directions for use. CONTRAINDICATIONS: Do not use in dogs with known tympanic membrane perforation (see PRECAUTIONS). CLARO® is contraindicated in dogs with known or suspected hypersensitivity to orfenicol, terbinane hydrochloride, or mometasone furoate, the inactive ingredients listed above, or similar drugs, or any ingredient in these medicines. WARNINGS: Human Warnings: Not for use in humans.
    [Show full text]
  • Special Bacteriology Basic Laboratory Tests
    2016 UNIVERZITA KOMENSKÉHO V BRATISLAVE JESSENIOVA LEKÁRSKA FAKULTA V MARTINE Jana KOMPANÍKOVÁ Martina NEUSCHLOVÁ Vladimíra SADLOŇOVÁ SPECIAL BACTERIOLOGY BASIC LABORATORY TESTS Preface Special Bacteriology – Basic Laboratory Tests is intended above all for medical students. The book includes standard procedures commonly used in microbiological laboratory. We have tried to present principles of laboratory tests to make them easier to understand. Authors Contents 1 STAPHYLOCOCCI ........................................................................................................ 5 1.1 GRAM STAIN ................................................................................................................... 7 1.2 STAPHYLOCOCCI - BLOOD AGAR CULTURE .................................................................... 7 1.3 CATALASE TEST ............................................................................................................... 8 1.4 MANNITOL SALT AGAR CULTURE ................................................................................... 9 1.5 COAGULASE TEST ......................................................................................................... 11 2 STREPTOCOCCI ........................................................................................................ 14 2.1 STREPTOCOCCI - GRAM STAIN ..................................................................................... 15 2.2 STREPTOCOCCI - BLOOD AGAR CULTURE ....................................................................
    [Show full text]
  • CDC, ASM, APHL: Basic Protocols for Level a Laboratories for The
    BASIC PROTOCOLS FOR LEVEL A LABORATORIES FOR THE PRESUMPTIVE IDENTIFICATION OF Francisella tularensis CDC Centers for Disease Control and Prevention ASM American Society for Microbiology APHL Association of Public Health Laboratories ftu.asm.cp.121301 12/13/01 Page 1 of 13 Credits: Francisella tularensis Subject Matter Expert, CDC May C. Chu, Ph.D. Centers for Disease Control and Prevention Subject Matter Expert, ASM Roberta B. Carey, Ph.D., D (ABMMM) Loyola University Medical Center David F. Welch, Ph.D., D (ABMMM) University of Texas Southwestern Medical Center Acknowledgments Thomas J. Quan, Ph.D. Centers for Disease Control and Prevention As well as: Zenda L. Berrada, Holly B. Bratcher, Leon G. Carter, Devin W. Close, Katie L. Davis, Todd S. Deppe, Kiyotaka R. Tsuchiya, Betty A. Wilmoth, Brook M. Yockey, and David T. Dennis Technical Editor Stephen A. Morse, M.S.P.H., Ph.D. Centers for Disease Control and Prevention ftu.asm.cp.121301 12/13/01 Page 2 of 13 Table of Contents: Francisella tularensis I. General information A. Description of organism B. History C. Geographic distribution D. Clinical presentation II. Procedures A. General B. Precautions C. Specimen 1. Acceptable specimens 2. Specimen handling 3. Rejection criteria D. Materials 1. Media 2. Reagents 3. Equipment/supplies E. Quality control F. Stains and smears G. Cultures H. Biochemical reactions/tests I. Interpretation and reporting 1. Suspected criteria 2. Reporting/appropriate action J. Limitations III. References ftu.asm.cp.121301 12/13/01 Page 3 of 13 I. General information A. Description of organism Francisella tularensis (F. tularensis) is a tiny, pleomorphic, nonmotile, gram-negative, facultative intracellular coccobacillus (0.2 to 0.5 µm by 0.7 to 1.0 µm).
    [Show full text]
  • Streptococcus Laboratory General Methods
    The reference used for compiling the methods in Section I is: Murray, P.R., Baron, E. J., Jorgensen, J.J., Pfaller, M.A., and Yolken, R.H. Manual of Clinical Microbiology, 8th ed. ASM Press: Washington, DC, 2003. The Streptococcus species identification methods in Section II were compiled by Dr. Lynn Shewmaker. Also thanks to input from several individuals, including Richard Facklam and Lucia Teixeira. Section I. 1. Accuprobe-Enterococcus Test………….………..4 2. Accuprobe-Pneumococcus Test …………..….….4 3. Acid formation in carbohydrate broth..................5 4. Arginine Hydrolysis……………………….……….6 5. Bacitracin Test……………………………………..7 6. Bile-esculin Test…………………………………...8 7. Bile solubility Test …………………………………9 8. CAMP Test…......................................................10 9. Catalase Test......................................................11 10. Clindamycin test………………………………….12 11. Esculin hydrolysis……………………………….. 13 12. Gas from MRS broth……………………………...14 13. Gram Stain………………………………………...15 14. Growth at 10 & 45C……………………………. 17 15. Hemolysis………………………………………….18 16. Hippurate hydrolysis…………………………… 19 17. Lancefield Group Antigen………………………..20 18. Leucine amino peptidase (LAP)…………………21 19. Litmus Milk Test…………………………………..22 20. Motility………………………………………………23 21. 6.5% NaCl Tolerace Test...................................24 22. Optochin…………………………………………….25 23. Pigmentation....................................................... 26 24. Pyridoxal Requirement Test (Vitamin B6)……….27 25. Pyrrolidonlarylamindase (PYR)............................28 26.
    [Show full text]
  • LAB 5. Fermentation and Respiration
    LAB 5. Fermentation and Respiration Protocols for Anaerobic growth, including use of Anaerobe Chamber, Catalase Assay, Oxidase Assay, Assay for Carbohydrate Utilization, Use of Oxidative-Fermentation tubes. INTRODUCTION Organisms that use preformed organic compounds as their source of carbon and energy are called chemoheterotrophs. Chemoheterotrophs exhibit two basic strategies of energy production: respiration and fermentation. To produce energy, both processes depend upon the flow of electrons from a substrate to a terminal electron acceptor. The electron acceptor (having a negative reduction potential) accepts electrons readily from the substrate (having a positive reduction potential). Respiration is the more efficient process whereby the substrate molecule is completely oxidized to CO2, and a maximum amount of energy is released. This process most commonly uses an inorganic molecule to serve as the final electron acceptor (O2 in aerobic respiration). Fermentation is less efficient. The substrate, commonly a sugar such as glucose, is not completely oxidized. Rather, the substrate is broken down to form pyruvate which still harbors potential energy. In fermentation the electrons from oxidation flow to an organic electron acceptor (pyruvate, or a byproduct of pyruvate) resulting in the formation of fermentation end products. The chemistry of endproducts formed during fermentation will vary depending upon the steps in this second portion of the fermentation pathway. The diversity within heterotrophic organisms can be seen in the pathways
    [Show full text]
  • Effect of CO2 Concentration on the Growth of Anaerobic Bacteria
    APPLIED MICROBIOLOGY, June 1974, p.1098-1104 Vol. 27, No. 6 Copyright 0 1974 American Society for Microbiology Printed in U.S.A. Effect of Culture Medium and Carbon Dioxide Concentration on Growth of Anaerobic Bacteria Commonly Encountered in Clinical Specimens DON R. STALONS, CLYDE THORNSBERRY, AND V. R. DOWELL, JR. Department of Parasitology and Laboratory Practice, School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27514, and the Center for Disease Control, Atlanta. Georgia 30333 Received for publication 19 December 1973 Representative strains of anaerobic bacteria from human infections were used to evaluate broth media, gas mixtures, and inocula for use in developing a procedure for performing minimal inhibitory concentration antimicrobic suscep- tibility tests. Nine commercially available media, including two that were chemically defined, were tested. Tests were performed in atmospheres with carbon dioxide concentrations between 2.5 and 10% and also in the GasPak system (BBL) that had a disposable hydrogen-carbon dioxide generator. Growth curves on each organism grown in Schaedler broth and a 5% carbon dioxide atmosphere were used to determine growth characteristics, equate time of the particular growth phases to turbidity readings, and determine the numbers of viable organisms present in the culture. Schaedler broth proved to be most advantageous in combination with an atmosphere of 5% carbon dioxide, 10% hydrogen, and 85% nitrogen. The growth curve studies yielded valuable data on the rapidity and quantity of growth under these conditions. We believe these data have provided information which can be used as the basis for developing a standardized procedure for antimicrobic susceptibility testing for anaerobic bacteria.
    [Show full text]
  • E17.Full-Text.Pdf
    Recovery of Anaerobic Bacteria From Four Children With Postthoracotomy Sternal Wound Infection Itzhak Brook, MD, MSc ABSTRACT. The cases of 4 children who developed purulent contents into a syringe that was immediately sealed and postthoracotomy sternal wound infection caused by an- transported to the laboratory within 30 minutes or by swab that aerobic bacteria are presented. The predominate anaer- was dipped into the pus and introduced into an anaerobic trans- obes were Peptostreptococcus species and pigmented port system (Port-A-Cul; BBL Microbiology Systems, Cock- eysville, MD) or a Vacutainer (BD Vacutainer System, Rutherford, Prevotella species. Polymicrobial infection was present NJ) and transported to the laboratory within 2 hours. in all cases, and aerobic bacteria also were recovered in 2 Sheep’s blood (5%), chocolate, and MacConkey agar plates instances. All patients responded to surgical debride- were inoculated at 37°C aerobically (MacConkey) or under 5% ment and antimicrobials effective against the isolated CO2 (blood and chocolate) and examined at 24 and 48 hours. For aerobic and anaerobic bacteria. These findings highlight isolation of anaerobes, the specimen material was plated onto the potential importance of anaerobic bacteria in post- prereduced vitamin K1-enriched Brucella blood agar, an anaerobic thoracotomy sternal wound infection. Pediatrics 2001; blood agar plate containing kanamycin and vancomycin, and an 108(1). URL: http://www.pediatrics.org/cgi/content/full/ aerobic blood plate containing colistin and nalidixic acid and 12 108/1/e17; anaerobic bacteria, Peptostreptococcus species, inoculated into an enriched thioglycolate broth, incubated in GasPak jars (BBL Microbiology Systems), and examined at 48 and Prevotella species, Staphylococcus aureus, sternal wound.
    [Show full text]